Toggle menu

ExPRES SEPSIS

Start date:
January 2014
End date:
July 2015
Co-ordinated by:
University of Edinburgh & NHS Lothian

Early Prediction of Severe Sepsis

Aim

To derive a biomarker to allow the identification of patients with confirmed sepsis, and risk stratify patients at risk of developing severe sepsis

Trial Design

A Prospective, multi-centre cohort observational study

Chief Investigator

Professor Tim Walsh, Critical Care Research Group

Local PI

Professor Tim Walsh

Research Team

  • EMERGE Research team
  • Critical Care Research Group
  • Rossi Lab, MRC Centre for Inflammation Research, Queens Medical Research Institute, University of Edinburgh

Eligibility criteria (summary)

Patients who present to the Emergency Department with suspected sepsis

Further information

http://www.ccm.mvm.ed.ac.uk/

http://www.cir.ed.ac.uk/

Research Team

Dr Deepankar Datta

Specialist Trainee Emergency Medicine

Julia Grahamslaw

Lead Research Nurse

Related news

Dip Dazzles at RCEM

Dip Dazzles at RCEM

9 Oct 2015 | Rachel O'Brien

Read more

More EMERGE Trials

DASH

DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more

NOVEL Study

Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions